PTK 0796

DRUG3 trials

Sponsors

Paratek Pharmaceuticals Inc

Conditions

Bacterial Skin DiseaseInfectious Skin DiseaseSkin Diseases, InfectiousSkin Structures and Soft Tissue Infections

Phase 2

Study the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

CompletedNCT03716024

Paratek Pharmaceuticals IncBacterial Skin Disease, Infectious Skin Disease

Start: 2007-07-18End: 2008-01-07Updated: 2020-10-12

Phase 3

Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

TerminatedNCT00865280

Paratek Pharmaceuticals IncSkin Diseases, Infectious

Start: 2009-04-04End: 2010-04-15Updated: 2021-03-12

Phase 3 Study - Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

WithdrawnNCT00876850

Paratek Pharmaceuticals IncSkin Structures and Soft Tissue Infections

Start: 2009-07-31End: 2010-08-31Updated: 2012-05-09